Education
About Us
Working with TipRanks
Follow Us
Hims & Hers Health (DE:82W)
FRANKFURT:82W
Total Valuation
Hims & Hers Health has a market cap or net worth of €6.76B. The enterprise value is €14.59B.
Market Cap€6.76B
Enterprise Value€14.59B
Share Statistics
Hims & Hers Health has 219,270,890 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding219,270,890
Owned by Insiders5.53%
Owned by Institutions23.42%
Financial Efficiency
Hims & Hers Health’s return on equity (ROE) is 0.26 and return on invested capital (ROIC) is 22.29%.
Return on Equity (ROE)0.26
Return on Assets (ROA)0.18
Return on Invested Capital (ROIC)22.29%
Return on Capital Employed (ROCE)0.13
Revenue Per Employee901.96K
Profits Per Employee76.99K
Employee Count1,637
Asset Turnover2.09
Inventory Turnover4.71
Valuation Ratios
The current PE Ratio of Hims & Hers Health is 59.8. Hims & Hers Health’s PEG ratio is -0.07.
PE Ratio59.8
PS Ratio3.54
PB Ratio10.95
Price to Fair Value10.95
Price to FCF26.33
Price to Operating Cash Flow37.99
PEG Ratio-0.07
Income Statement
In the last 12 months, Hims & Hers Health had revenue of 1.48B and earned 126.04M in profits. Earnings per share was 0.58.
Revenue1.48B
Gross Profit1.17B
Operating Income61.90M
Pretax Income71.71M
Net Income126.04M
EBITDA78.99M
Earnings Per Share (EPS)0.58
Cash Flow
In the last 12 months, operating cash flow was 325.08M and capital expenditures -193.54M, giving a free cash flow of 131.54M billion.
Operating Cash Flow325.08M
Free Cash Flow131.54M
Free Cash Flow per Share0.60
Dividends & Yields
Hims & Hers Health pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta2.14
52-Week Price Change13.07%
50-Day Moving Average35.54
200-Day Moving Average40.15
Relative Strength Index (RSI)38.21
Average Volume (3m)1.67K
Important Dates
Hims & Hers Health upcoming earnings date is Mar 2, 2026, TBA (Confirmed).
Last Earnings DateNov 3, 2025
Next Earnings DateMar 2, 2026
Ex-Dividend Date―
Financial Position
Hims & Hers Health as a current ratio of 1.79, with Debt / Equity ratio of 185.60%
Current Ratio1.79
Quick Ratio1.50
Debt to Market Cap0.00
Net Debt to EBITDA-2.65
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Hims & Hers Health has paid -54.33M in taxes.
Income Tax-54.33M
Effective Tax Rate-0.76
Enterprise Valuation
Hims & Hers Health EV to EBITDA ratio is 63.45, with an EV/FCF ratio of 25.27.
EV to Sales3.39
EV to EBITDA63.45
EV to Free Cash Flow25.27
EV to Operating Cash Flow19.96
Balance Sheet
Hims & Hers Health has €629.74M in cash and marketable securities with €1.12B in debt, giving a net cash position of -€488.28M billion.
Cash & Marketable Securities€629.74M
Total Debt€1.12B
Net Cash-€488.28M
Net Cash Per Share-€2.23
Tangible Book Value Per Share€1.48
Margins
Gross margin is 76.20%, with operating margin of 4.19%, and net profit margin of 8.54%.
Gross Margin76.20%
Operating Margin4.19%
Pretax Margin4.86%
Net Profit Margin8.54%
EBITDA Margin5.35%
EBIT Margin4.19%
Analyst Forecast
The average price target for Hims & Hers Health is €37.97, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target€37.97
Price Target Upside28.36% Upside
Analyst ConsensusHold
Analyst Count11
Revenue Growth Forecast―
EPS Growth Forecast―